We are live on ! Find out more
OMIC

Singular Genomics Systems, Inc. Common Stock
OMIC

Delisted

OMIC was delisted on the 20th of February, 2025.

Back to rankings

62 hedge funds and large institutions have $450M invested in Singular Genomics Systems, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 24 increasing their positions, 8 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 8

100% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 10

44% more capital invested

Capital invested by funds: $312M → $450M (+$138M)

19% more funds holding

Funds holding: 52 → 62 (+10)

Holders
62
Holders Change
+10
Holders Change %
+19.23%
% of All Funds
0.95%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
20
Increased
24
Reduced
8
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$16.7M
2
JP Morgan Chase
JP Morgan Chase
New York
+$8.24M
3
BlackRock
BlackRock
New York
+$6.34M
4
PA
Perceptive Advisors
New York
+$3.36M
5
PIM
Platinum Investment Management
Australia
+$2.02M

Top Sellers

Rank Fund Capital Flow
1
CC
Casdin Capital
New York
-$16.2M
2
Marshall Wace
Marshall Wace
United Kingdom
-$5.23M
3
Millennium Management
Millennium Management
New York
-$5.08M
4
JPC
Jabodon PT Co
Nevada
-$1.11M
5
PAMS
Pictet Asset Management (Switzerland)
Switzerland
-$891K
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
51
Deutsche Bank
Germany
$83K +$5.04K +13 +6%
AIG
52
American International Group
New York
$74K -$1.16K -3 -1%
California State Teachers Retirement System (CalSTRS)
53
California State Teachers Retirement System (CalSTRS)
California
$74K – – –
FIA
54
FNY Investment Advisers
New York
$57K +$64.7K +167 New
Royal Bank of Canada
55
Royal Bank of Canada
Ontario, Canada
$33K +$6.2K +16 +20%
TRCT
56
Tower Research Capital (TRC)
New York
$24K +$14.7K +38 +115%
Legal & General Group
57
Legal & General Group
United Kingdom
$13K – – –
AIP
58
Ameritas Investment Partners
Nebraska
$10K – – –
Wells Fargo
59
Wells Fargo
California
$3K +$3.1K +8 +400%
Daiwa Securities Group
60
Daiwa Securities Group
Japan
$2K +$2.71K +7 New
SOW
61
State of Wyoming
Wyoming
$1K – – –
CAPTRUST Financial Advisors
62
CAPTRUST Financial Advisors
North Carolina
$1K +$1.16K +3 New
Millennium Management
63
Millennium Management
New York
– -$5.08M -15,140 Closed
JPC
64
Jabodon PT Co
Nevada
– -$1.11M -3,306 Closed
PAMS
65
Pictet Asset Management (Switzerland)
Switzerland
– -$891K -2,654 Closed
NAM
66
Nexpoint Asset Management
Texas
– -$760K -2,265 Closed
CCM
67
CAAS Capital Management
New York
– -$336K -1,000 Closed
GCM
68
Ghisallo Capital Management
Massachusetts
– -$168K -500 Closed
Two Sigma Investments
69
Two Sigma Investments
New York
– -$150K -448 Closed
Federated Hermes
70
Federated Hermes
Pennsylvania
– -$112K -333 Closed
HI
71
Harbour Investments
Wisconsin
– -$2K -6 Closed
Rockefeller Capital Management
72
Rockefeller Capital Management
New York
– -$1K -3 Closed
1 2
3

OMIC Hedge Fund Activity: Q4 2021 in Review

62 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Singular Genomics Systems, Inc. Common Stock (OMIC) for Q4 2021, worth a combined $450M — up 44% from $312M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new OMIC positions and 10 closed out — a net gain of 10 holders — while 24 added to existing stakes and 8 trimmed.

The largest buyer was Vanguard Group, adding an estimated $16.7M. The largest seller was Casdin Capital, cutting an estimated $16.2M.

  • 62 institutional investors held Singular Genomics Systems, Inc. Common Stock (OMIC) as of Q4 2021, up from 52 in Q3 2021.
  • Funds reported $450M of Singular Genomics Systems, Inc. Common Stock stock for Q4 2021, up 44% quarter-over-quarter.
  • 20 funds opened new Singular Genomics Systems, Inc. Common Stock positions in Q4 2021 and 10 closed out, a net change of +10 holders.
  • The largest Singular Genomics Systems, Inc. Common Stock buyer in Q4 2021 was Vanguard Group, an estimated $16.7M added.
  • The largest Singular Genomics Systems, Inc. Common Stock seller in Q4 2021 was Casdin Capital, an estimated $16.2M sold.

Based on aggregated 13F filings for Q4 2021.